Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis | 4 | 2022 | 88 | 1.380 |
Why?
|
| Complement System Proteins | 4 | 2010 | 134 | 0.950 |
Why?
|
| Hemolytic-Uremic Syndrome | 3 | 2006 | 48 | 0.580 |
Why?
|
| Influenza Vaccines | 3 | 2024 | 496 | 0.470 |
Why?
|
| Influenza, Human | 3 | 2024 | 761 | 0.410 |
Why?
|
| Membrane Cofactor Protein | 3 | 2006 | 11 | 0.410 |
Why?
|
| Adenovirus Infections, Human | 2 | 2023 | 55 | 0.410 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2024 | 213 | 0.400 |
Why?
|
| Adenoviridae Infections | 2 | 2022 | 114 | 0.390 |
Why?
|
| Ectromelia virus | 1 | 2010 | 3 | 0.360 |
Why?
|
| Complement Inactivating Agents | 1 | 2010 | 17 | 0.360 |
Why?
|
| Immune Evasion | 1 | 2010 | 72 | 0.350 |
Why?
|
| Ectromelia, Infectious | 1 | 2008 | 3 | 0.330 |
Why?
|
| Virulence Factors | 1 | 2010 | 231 | 0.310 |
Why?
|
| Viral Proteins | 1 | 2010 | 478 | 0.290 |
Why?
|
| Acute Disease | 4 | 2022 | 2492 | 0.250 |
Why?
|
| Liver Transplantation | 2 | 2023 | 1187 | 0.220 |
Why?
|
| Adenoviruses, Human | 1 | 2022 | 191 | 0.190 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 98 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2024 | 7046 | 0.180 |
Why?
|
| Child | 12 | 2024 | 30558 | 0.180 |
Why?
|
| Gastroenteritis | 1 | 2023 | 350 | 0.170 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 494 | 0.150 |
Why?
|
| Lung Transplantation | 1 | 2021 | 380 | 0.140 |
Why?
|
| Transplant Recipients | 3 | 2024 | 335 | 0.130 |
Why?
|
| Complement Activation | 2 | 2006 | 86 | 0.130 |
Why?
|
| Viremia | 2 | 2022 | 157 | 0.120 |
Why?
|
| Betacoronavirus | 1 | 2020 | 514 | 0.120 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2024 | 136 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 853 | 0.100 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 623 | 0.100 |
Why?
|
| Alabama | 2 | 2022 | 45 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 701 | 0.100 |
Why?
|
| Cell Line | 3 | 2010 | 5313 | 0.100 |
Why?
|
| Cricetulus | 1 | 2010 | 214 | 0.090 |
Why?
|
| Neutralization Tests | 1 | 2010 | 236 | 0.090 |
Why?
|
| Exons | 2 | 2006 | 1388 | 0.080 |
Why?
|
| Child, Preschool | 5 | 2024 | 17075 | 0.080 |
Why?
|
| Cricetinae | 1 | 2010 | 744 | 0.080 |
Why?
|
| Mutation | 2 | 2006 | 15905 | 0.080 |
Why?
|
| Hepatitis, Viral, Animal | 1 | 2008 | 5 | 0.080 |
Why?
|
| Complement C4 | 1 | 2008 | 14 | 0.080 |
Why?
|
| Complement Factor B | 1 | 2008 | 11 | 0.080 |
Why?
|
| Complement C3 | 1 | 2008 | 80 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 7050 | 0.080 |
Why?
|
| Humans | 16 | 2024 | 270601 | 0.070 |
Why?
|
| Infant | 4 | 2022 | 13992 | 0.070 |
Why?
|
| Necrosis | 1 | 2008 | 591 | 0.070 |
Why?
|
| Complement C3b | 1 | 2005 | 9 | 0.070 |
Why?
|
| Virus Replication | 1 | 2008 | 762 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2008 | 697 | 0.060 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2024 | 108 | 0.060 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2024 | 96 | 0.050 |
Why?
|
| Vaccines, Inactivated | 1 | 2024 | 140 | 0.050 |
Why?
|
| Escherichia coli Infections | 1 | 2005 | 262 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2024 | 378 | 0.050 |
Why?
|
| Pandemics | 2 | 2022 | 1608 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2008 | 5692 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 709 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2021 | 192 | 0.050 |
Why?
|
| Untranslated Regions | 1 | 2000 | 15 | 0.050 |
Why?
|
| Homeostasis | 1 | 2005 | 926 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2000 | 113 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 3582 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 280 | 0.040 |
Why?
|
| Mice | 3 | 2010 | 35412 | 0.040 |
Why?
|
| Eosinophils | 1 | 2000 | 166 | 0.040 |
Why?
|
| Liver | 1 | 2008 | 3056 | 0.040 |
Why?
|
| Adolescent | 3 | 2024 | 32684 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2022 | 819 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 2478 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2004 | 1626 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2023 | 1490 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 1218 | 0.040 |
Why?
|
| Asthma | 1 | 2004 | 893 | 0.030 |
Why?
|
| Animals | 3 | 2010 | 61346 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 3328 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 796 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2021 | 1246 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2000 | 3205 | 0.030 |
Why?
|
| Male | 4 | 2022 | 128395 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 5144 | 0.020 |
Why?
|
| Hospitalization | 1 | 2020 | 2170 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 7311 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 6445 | 0.020 |
Why?
|
| Prognosis | 1 | 2006 | 22520 | 0.020 |
Why?
|
| Adult | 2 | 2022 | 81960 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8602 | 0.020 |
Why?
|
| Antigens, Fungal | 1 | 2004 | 42 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 207 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2004 | 66 | 0.010 |
Why?
|
| Haplotypes | 1 | 2006 | 908 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2004 | 175 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2004 | 388 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2004 | 136 | 0.010 |
Why?
|
| Female | 2 | 2020 | 148790 | 0.010 |
Why?
|
| Allergens | 1 | 2004 | 253 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 22219 | 0.010 |
Why?
|
| Receptors, CCR3 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 750 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2000 | 275 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 719 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 2419 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2000 | 509 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 33811 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 39922 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2000 | 610 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 1471 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 3109 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 1557 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 3464 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 5405 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 1362 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 6639 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 2561 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 3041 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2000 | 6344 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 4105 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2004 | 12041 | 0.000 |
Why?
|